Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2023-12-14 · Environmental Protection Agency (EPA) · Notices

Notices. Notice; extension of comment period

367 words·~2 min read·/register/2023/12/14/2023-27405·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 6717-01-P ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-OPP-2023-0474; FRL-11384-02-OCSPP] Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Extension of Comment Period AGENCY: Environmental Protection Agency (EPA). ACTION: Notice; extension of comment period. SUMMARY: In the **Federal Register** of October 27, 2023, EPA announced the availability of and solicited comment on near-term strategies to help the Agency meet its obligations and commitments under the Federal Food, Drug, and Cosmetic Act (FFDCA), which requires, that EPA screen for and protect against endocrine disrupting effects in humans.
This document extends the comment period, which was scheduled to end on December 26, 2023, for 60 days. DATES: The comment period for the document published in the **Federal Register** of October 27, 2023, at 88 FR 73841 (FRL-11384-01-OCSPP) is extended. Comments must be received on or before February 26, 2023. ADDRESSES: Submit your comments, identified by docket identification
(ID)number EPA-HQ-OPP-2023-0474, through the Federal eRulemaking Portal at *https://www.regulations.gov.* Follow the online instructions for submitting comments. Do not submit electronically any information you consider to be Confidential Business Information
(CBI)or other information whose disclosure is restricted by statute. Additional instructions on commenting and visiting the docket, along with more information about dockets generally, is available at *https://www.epa.gov/dockets.* FOR FURTHER INFORMATION CONTACT: Catherine Aubee, Endocrine Disruptor Screening Program (7505T), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; main telephone number:
(202)566-1030; email address: *pesticidequestions@epa.gov.* SUPPLEMENTARY INFORMATION: To give stakeholders additional time to review materials and prepare comments, EPA is hereby extending the comment period established in the **Federal Register** document of October 27, 2023, at 88 FR 73841 (FRL-11884-01-OCSPP) for 60 days, from December 26, 2023, to February 26, 2023. More information on the action can be found in the **Federal Register** of October 27, 2023. To submit comments or access the docket, please follow the detailed instructions provided under ADDRESSES . If you have questions, consult the technical person listed under FOR FURTHER INFORMATION CONTACT . (Authority: 7 U.S.C. 136 *et seq.* and 21 U.S.C. 346a) Dated: December 6, 2023. Michal Freedhoff, Assistant Administrator, Office of Chemical Safety and Pollution Prevention. [FR Doc. 2023-27405 Filed 12-13-23; 8:45 am]
Connectionstraces to 2
Citation graph
cites case law
Notices
Notice; extension of comment period
Cites 2Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.